Anti-Cisplatin modified DNA antibody [CP9/19] (ab103261)

Publishing research using ab103261? Please let us know so that we can cite the reference in this datasheet.

ab103261 has been referenced in 4 publications.

  • Rocha CR  et al. Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo. Cell Death Dis 5:e1505 (2014). Dot blot, ICC/IF ; Human . PubMed: 25356874
  • Lundholm L  et al. Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest. Cell Death Dis 4:e478 (2013). Flow Cyt ; Human . PubMed: 23370278
  • Jazaeri AA  et al. Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924. Mol Cancer Ther 12:1958-67 (2013). PubMed: 23939375
  • Tilby MJ  et al. Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody. Cancer Res 51:123-9 (1991). PubMed: 1703029

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"